0001179110-19-001941.txt : 20190215
0001179110-19-001941.hdr.sgml : 20190215
20190215084109
ACCESSION NUMBER: 0001179110-19-001941
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190213
FILED AS OF DATE: 20190215
DATE AS OF CHANGE: 20190215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Donovan Joanne M.
CENTRAL INDEX KEY: 0001644087
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 19609933
MAIL ADDRESS:
STREET 1: C/O CATABASIS PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQ. BLDG. 1400E SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2019-02-13
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001644087
Donovan Joanne M.
C/O CATABASIS PHARMACEUTICALS, INC.
ONE KENDALL SQ, BLDG 1400E, STE B14202
CAMBRIDGE
MA
02139
0
1
0
0
CMO; SVP Clinical Development
Stock Option (right to buy)
4.39
2019-02-13
4
A
0
40000
0
A
2029-02-12
Common Stock
40000
40000
D
This option was granted on February 13, 2019 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 13, 2019 and the remainder vesting over the ensuing three years at a rate of 2.0333% per month.
/s/ Deirdre A. Cunnane as attorney-in-fact for Joanne Donovan
2019-02-15